| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.09e-04 | 8 | 40 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.47e-04 | 134 | 40 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.74e-04 | 10 | 40 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.61e-04 | 1356 | 40 | 10 | GO:0060090 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 7.27e-04 | 20 | 40 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.84e-03 | 1160 | 40 | 8 | GO:0030674 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.11e-08 | 36 | 43 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | synapse maturation | 3.52e-06 | 50 | 43 | 4 | GO:0060074 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.94e-05 | 159 | 43 | 5 | GO:0006888 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 3.64e-05 | 31 | 43 | 3 | GO:0090128 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 6.88e-05 | 339 | 43 | 6 | GO:0048193 | |
| GeneOntologyBiologicalProcess | protein localization to cytoplasmic stress granule | 1.18e-04 | 8 | 43 | 2 | GO:1903608 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 2.31e-04 | 11 | 43 | 2 | GO:0070934 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.77e-04 | 12 | 43 | 2 | GO:1900152 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.95e-08 | 42 | 45 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 6.76e-05 | 6 | 45 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.95e-04 | 12 | 45 | 2 | GO:0044666 | |
| HumanPheno | Abnormal curvature of the vertebral column | KMT2C NDUFAF6 KMT2D COL11A2 SPG7 EIF4H ARVCF MYO9A LOX HNRNPK | 2.43e-05 | 1219 | 12 | 10 | HP:0010674 |
| HumanPheno | Inguinal hernia | 3.40e-05 | 312 | 12 | 6 | HP:0000023 | |
| HumanPheno | Hernia of the abdominal wall | 4.65e-05 | 506 | 12 | 7 | HP:0004299 | |
| HumanPheno | Abdominal wall defect | 4.96e-05 | 511 | 12 | 7 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 4.96e-05 | 511 | 12 | 7 | HP:0100656 | |
| HumanPheno | Gastroesophageal reflux | 5.36e-05 | 517 | 12 | 7 | HP:0002020 | |
| HumanPheno | Eversion of lateral third of lower eyelids | 7.59e-05 | 6 | 12 | 2 | HP:0007655 | |
| HumanPheno | Abnormal aortic arch morphology | 8.60e-05 | 109 | 12 | 4 | HP:0012303 | |
| HumanPheno | Abnormality of the abdominal wall | 9.03e-05 | 560 | 12 | 7 | HP:0004298 | |
| HumanPheno | Vesicoureteral reflux | 9.06e-05 | 221 | 12 | 5 | HP:0000076 | |
| HumanPheno | Bicuspid aortic valve | 1.21e-04 | 119 | 12 | 4 | HP:0001647 | |
| HumanPheno | Hernia | 1.25e-04 | 589 | 12 | 7 | HP:0100790 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 1.29e-04 | 121 | 12 | 4 | HP:0031567 | |
| HumanPheno | Scoliosis | 1.36e-04 | 1122 | 12 | 9 | HP:0002650 | |
| HumanPheno | Abnormal ureter physiology | 1.48e-04 | 245 | 12 | 5 | HP:0025634 | |
| HumanPheno | Abnormal esophagus physiology | 3.03e-04 | 933 | 12 | 8 | HP:0025270 | |
| HumanPheno | Abnormal aortic valve morphology | 3.23e-04 | 289 | 12 | 5 | HP:0001646 | |
| HumanPheno | High, narrow palate | 3.46e-04 | 156 | 12 | 4 | HP:0002705 | |
| HumanPheno | Bifid uvula | 4.49e-04 | 167 | 12 | 4 | HP:0000193 | |
| HumanPheno | Abnormal thorax morphology | 5.42e-04 | 1328 | 12 | 9 | HP:0000765 | |
| HumanPheno | Abnormal stomach morphology | 5.49e-04 | 742 | 12 | 7 | HP:0002577 | |
| HumanPheno | Nocturnal hypoventilation | 5.99e-04 | 16 | 12 | 2 | HP:0002877 | |
| HumanPheno | Subpleural honeycombing | 5.99e-04 | 16 | 12 | 2 | HP:0031631 | |
| HumanPheno | Abnormal subpleural morphology | 6.78e-04 | 17 | 12 | 2 | HP:0031630 | |
| Domain | FYrich_C | 4.23e-05 | 5 | 39 | 2 | IPR003889 | |
| Domain | FYrich_N | 4.23e-05 | 5 | 39 | 2 | IPR003888 | |
| Domain | FYRC | 4.23e-05 | 5 | 39 | 2 | SM00542 | |
| Domain | FYRN | 4.23e-05 | 5 | 39 | 2 | SM00541 | |
| Domain | FYRN | 4.23e-05 | 5 | 39 | 2 | PF05964 | |
| Domain | FYRC | 4.23e-05 | 5 | 39 | 2 | PF05965 | |
| Domain | FYRC | 4.23e-05 | 5 | 39 | 2 | PS51543 | |
| Domain | FYRN | 4.23e-05 | 5 | 39 | 2 | PS51542 | |
| Domain | Post-SET_dom | 5.01e-04 | 16 | 39 | 2 | IPR003616 | |
| Domain | PostSET | 5.01e-04 | 16 | 39 | 2 | SM00508 | |
| Domain | AT_hook | 5.01e-04 | 16 | 39 | 2 | PF02178 | |
| Domain | POST_SET | 5.01e-04 | 16 | 39 | 2 | PS50868 | |
| Domain | EPHD | 9.56e-04 | 22 | 39 | 2 | PS51805 | |
| Domain | Znf_C2H2_jaz | 9.56e-04 | 22 | 39 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 9.56e-04 | 22 | 39 | 2 | PF12171 | |
| Domain | HRM | 1.55e-03 | 28 | 39 | 2 | PF02793 | |
| Domain | ZnF_U1 | 1.66e-03 | 29 | 39 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.66e-03 | 29 | 39 | 2 | IPR003604 | |
| Domain | RA | 1.90e-03 | 31 | 39 | 2 | SM00314 | |
| Domain | HMGI/Y_DNA-bd_CS | 1.90e-03 | 31 | 39 | 2 | IPR000637 | |
| Domain | GPS | 2.29e-03 | 34 | 39 | 2 | SM00303 | |
| Domain | GPS | 2.42e-03 | 35 | 39 | 2 | PF01825 | |
| Domain | RA | 2.56e-03 | 36 | 39 | 2 | PF00788 | |
| Domain | GPS | 2.56e-03 | 36 | 39 | 2 | PS50221 | |
| Domain | GPS | 2.70e-03 | 37 | 39 | 2 | IPR000203 | |
| Domain | RA | 2.70e-03 | 37 | 39 | 2 | PS50200 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.15e-03 | 40 | 39 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 3.15e-03 | 40 | 39 | 2 | IPR001879 | |
| Domain | Laminin_G_2 | 3.15e-03 | 40 | 39 | 2 | PF02210 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.15e-03 | 40 | 39 | 2 | PS50227 | |
| Domain | RA_dom | 3.15e-03 | 40 | 39 | 2 | IPR000159 | |
| Domain | SET | 3.31e-03 | 41 | 39 | 2 | PF00856 | |
| Domain | LamG | 3.80e-03 | 44 | 39 | 2 | SM00282 | |
| Domain | SET | 4.15e-03 | 46 | 39 | 2 | SM00317 | |
| Domain | SET_dom | 4.89e-03 | 50 | 39 | 2 | IPR001214 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.89e-03 | 50 | 39 | 2 | PS00650 | |
| Domain | 7tm_2 | 4.89e-03 | 50 | 39 | 2 | PF00002 | |
| Domain | SET | 4.89e-03 | 50 | 39 | 2 | PS50280 | |
| Domain | HMG_box | 5.47e-03 | 53 | 39 | 2 | PF00505 | |
| Domain | HMG | 5.68e-03 | 54 | 39 | 2 | SM00398 | |
| Domain | Laminin_G | 6.52e-03 | 58 | 39 | 2 | IPR001791 | |
| Domain | GPCR_2_secretin-like | 6.97e-03 | 60 | 39 | 2 | IPR000832 | |
| Domain | GPCR_2-like | 6.97e-03 | 60 | 39 | 2 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 7.19e-03 | 61 | 39 | 2 | PS50261 | |
| Domain | RhoGAP | 7.42e-03 | 62 | 39 | 2 | SM00324 | |
| Domain | RhoGAP | 7.66e-03 | 63 | 39 | 2 | PF00620 | |
| Domain | RHOGAP | 7.89e-03 | 64 | 39 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 7.89e-03 | 64 | 39 | 2 | IPR000198 | |
| Domain | - | 7.89e-03 | 64 | 39 | 2 | 1.10.555.10 | |
| Domain | C1 | 8.13e-03 | 65 | 39 | 2 | SM00109 | |
| Domain | HMG_box_dom | 8.13e-03 | 65 | 39 | 2 | IPR009071 | |
| Domain | PE/DAG-bd | 8.38e-03 | 66 | 39 | 2 | IPR002219 | |
| Domain | RRM_1 | 9.27e-03 | 208 | 39 | 3 | PF00076 | |
| Domain | RRM | 1.04e-02 | 217 | 39 | 3 | SM00360 | |
| Pathway | WP_MRNA_PROCESSING | 4.42e-05 | 451 | 31 | 7 | MM15946 | |
| Pathway | WP_MRNA_PROCESSING | 1.59e-04 | 126 | 31 | 4 | M39406 | |
| Pubmed | 1.43e-07 | 469 | 45 | 8 | 27634302 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 28483418 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 36869380 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 28967912 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 1.64e-06 | 2 | 45 | 2 | 34156443 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21849455 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 25346535 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 31924266 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 27280393 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 36601880 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 38279484 | ||
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 4.91e-06 | 3 | 45 | 2 | 22183980 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 31116584 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23857582 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23932714 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21683083 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 8.54e-06 | 1082 | 45 | 9 | 38697112 | |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 9.81e-06 | 4 | 45 | 2 | 19221051 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 34645806 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 28398509 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 24081332 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 9.81e-06 | 4 | 45 | 2 | 33718348 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 12586826 | ||
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 9.81e-06 | 4 | 45 | 2 | 27311593 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 31244610 | ||
| Pubmed | Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer. | 9.81e-06 | 4 | 45 | 2 | 36012594 | |
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 9.81e-06 | 4 | 45 | 2 | 23129768 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 21807889 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 23986595 | ||
| Pubmed | 1.59e-05 | 244 | 45 | 5 | 29884807 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 18630941 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 1.63e-05 | 5 | 45 | 2 | 12839582 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 19131326 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 1.63e-05 | 5 | 45 | 2 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 1.63e-05 | 5 | 45 | 2 | 38439956 | |
| Pubmed | MLL3/MLL4-Associated PAGR1 Regulates Adipogenesis by Controlling Induction of C/EBPβ and C/EBPδ. | 1.63e-05 | 5 | 45 | 2 | 32601106 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 1.63e-05 | 5 | 45 | 2 | 21183079 | |
| Pubmed | Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF. | 1.63e-05 | 5 | 45 | 2 | 31127101 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 26744420 | ||
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 1.93e-05 | 40 | 45 | 3 | 23825951 | |
| Pubmed | Proteomic and genomic analysis of PITX2 interacting and regulating networks. | 2.45e-05 | 6 | 45 | 2 | 19174163 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 2.45e-05 | 6 | 45 | 2 | 17021013 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.79e-05 | 462 | 45 | 6 | 31138677 | |
| Pubmed | 2.96e-05 | 46 | 45 | 3 | 34265304 | ||
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 30604749 | ||
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 36598580 | ||
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 19556342 | ||
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 3.42e-05 | 7 | 45 | 2 | 29133483 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 4.10e-05 | 148 | 45 | 4 | 32538781 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 30335158 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 4.56e-05 | 8 | 45 | 2 | 23130995 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 22266653 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 4.56e-05 | 8 | 45 | 2 | 21447625 | |
| Pubmed | Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. | 4.56e-05 | 8 | 45 | 2 | 19029303 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 10809782 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.97e-05 | 1353 | 45 | 9 | 29467282 | |
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 22665483 | ||
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 5.86e-05 | 9 | 45 | 2 | 18342301 | |
| Pubmed | Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. | 5.86e-05 | 9 | 45 | 2 | 22767893 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 7.27e-05 | 336 | 45 | 5 | 31253590 | |
| Pubmed | 7.35e-05 | 172 | 45 | 4 | 26336360 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.43e-05 | 807 | 45 | 7 | 22681889 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 7.68e-05 | 1105 | 45 | 8 | 35748872 | |
| Pubmed | 7.69e-05 | 340 | 45 | 5 | 24332808 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 37012455 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 21900255 | ||
| Pubmed | The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. | 1.07e-04 | 12 | 45 | 2 | 31266968 | |
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 27563068 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.27e-04 | 13 | 45 | 2 | 17761849 | |
| Pubmed | 1.27e-04 | 13 | 45 | 2 | 21502505 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 1.27e-04 | 13 | 45 | 2 | 11839810 | |
| Pubmed | TDRD3 promotes DHX9 chromatin recruitment and R-loop resolution. | 1.47e-04 | 14 | 45 | 2 | 34329467 | |
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 18198266 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 12482968 | ||
| Pubmed | 1.48e-04 | 1215 | 45 | 8 | 15146197 | ||
| Pubmed | 1.61e-04 | 81 | 45 | 3 | 24965446 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.70e-04 | 922 | 45 | 7 | 27609421 | |
| Pubmed | Proteomic analysis of an interactome for long-form AMPA receptor subunits. | 1.70e-04 | 15 | 45 | 2 | 20131911 | |
| Pubmed | 1.70e-04 | 15 | 45 | 2 | 17925232 | ||
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 1.70e-04 | 15 | 45 | 2 | 30224460 | |
| Pubmed | 1.70e-04 | 15 | 45 | 2 | 25735744 | ||
| Pubmed | 1.77e-04 | 216 | 45 | 4 | 37640791 | ||
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 1.79e-04 | 84 | 45 | 3 | 19135240 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.89e-04 | 220 | 45 | 4 | 35785414 | |
| Pubmed | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | 1.94e-04 | 16 | 45 | 2 | 16230076 | |
| Pubmed | 1.94e-04 | 16 | 45 | 2 | 24368734 | ||
| Pubmed | 1.99e-04 | 223 | 45 | 4 | 30572598 | ||
| Pubmed | 1.99e-04 | 223 | 45 | 4 | 33731348 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.13e-04 | 89 | 45 | 3 | 22446626 | |
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 26180087 | ||
| Pubmed | 2.47e-04 | 18 | 45 | 2 | 28049845 | ||
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 2.47e-04 | 18 | 45 | 2 | 11149944 | |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 2.47e-04 | 18 | 45 | 2 | 17500065 | |
| Pubmed | 2.47e-04 | 18 | 45 | 2 | 27984743 | ||
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 2.47e-04 | 18 | 45 | 2 | 19497860 | |
| Pubmed | 2.48e-04 | 236 | 45 | 4 | 36339263 | ||
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 2.58e-04 | 95 | 45 | 3 | 37211047 | |
| Pubmed | 2.58e-04 | 441 | 45 | 5 | 12853948 | ||
| Pubmed | 2.60e-04 | 239 | 45 | 4 | 26641092 | ||
| Pubmed | 2.74e-04 | 97 | 45 | 3 | 25071155 | ||
| Interaction | CTAGE1 interactions | 3.74e-09 | 10 | 43 | 4 | int:CTAGE1 | |
| Interaction | FEZ1 interactions | 4.02e-05 | 90 | 43 | 4 | int:FEZ1 | |
| Interaction | MRGPRX4 interactions | 6.63e-05 | 6 | 43 | 2 | int:MRGPRX4 | |
| Interaction | MIA2 interactions | 9.77e-05 | 113 | 43 | 4 | int:MIA2 | |
| Interaction | EWSR1 interactions | 1.02e-04 | 906 | 43 | 9 | int:EWSR1 | |
| Interaction | SOX2 interactions | ZNF638 KMT2C KMT2D SSBP3 YBX1 MYO9A LOX RCOR2 HNRNPK DHX9 MSI2 | 1.46e-04 | 1422 | 43 | 11 | int:SOX2 |
| Interaction | KMO interactions | 1.59e-04 | 9 | 43 | 2 | int:KMO | |
| Interaction | KHDRBS2 interactions | 1.63e-04 | 129 | 43 | 4 | int:KHDRBS2 | |
| Interaction | NEUROG3 interactions | 2.83e-04 | 149 | 43 | 4 | int:NEUROG3 | |
| Interaction | MAGEL2 interactions | 2.99e-04 | 61 | 43 | 3 | int:MAGEL2 | |
| Interaction | MECP2 interactions | ZNF638 NSUN4 XRN2 ZNF593 ARHGAP23 YBX1 CECR2 RCOR2 HNRNPK DHX9 | 3.00e-04 | 1287 | 43 | 10 | int:MECP2 |
| Interaction | SUZ12 interactions | 3.90e-04 | 644 | 43 | 7 | int:SUZ12 | |
| Interaction | MEPCE interactions | 4.06e-04 | 859 | 43 | 8 | int:MEPCE | |
| Interaction | MDM2 interactions | 4.44e-04 | 658 | 43 | 7 | int:MDM2 | |
| Interaction | MIR9-3 interactions | 4.48e-04 | 70 | 43 | 3 | int:MIR9-3 | |
| Interaction | SP7 interactions | 4.55e-04 | 304 | 43 | 5 | int:SP7 | |
| Interaction | MIR29B2 interactions | 4.67e-04 | 71 | 43 | 3 | int:MIR29B2 | |
| Interaction | MIR18A interactions | 5.07e-04 | 73 | 43 | 3 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 5.07e-04 | 73 | 43 | 3 | int:MIR29B1 | |
| Interaction | ARIH2 interactions | 5.27e-04 | 314 | 43 | 5 | int:ARIH2 | |
| Interaction | MIR20A interactions | 5.28e-04 | 74 | 43 | 3 | int:MIR20A | |
| Interaction | MIR15A interactions | 5.49e-04 | 75 | 43 | 3 | int:MIR15A | |
| Interaction | MIR7-3 interactions | 5.71e-04 | 76 | 43 | 3 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 5.71e-04 | 76 | 43 | 3 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 5.71e-04 | 76 | 43 | 3 | int:MIR199A2 | |
| Interaction | MIR9-2 interactions | 5.93e-04 | 77 | 43 | 3 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 5.93e-04 | 77 | 43 | 3 | int:MIR200A | |
| Interaction | SPTAN1 interactions | 6.07e-04 | 496 | 43 | 6 | int:SPTAN1 | |
| Interaction | MIR92A1 interactions | 6.16e-04 | 78 | 43 | 3 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 6.16e-04 | 78 | 43 | 3 | int:MIR98 | |
| Interaction | MIR451A interactions | 6.16e-04 | 78 | 43 | 3 | int:MIR451A | |
| Interaction | MIR222 interactions | 6.39e-04 | 79 | 43 | 3 | int:MIR222 | |
| Interaction | MIR34C interactions | 6.39e-04 | 79 | 43 | 3 | int:MIR34C | |
| Interaction | MIR143 interactions | 6.63e-04 | 80 | 43 | 3 | int:MIR143 | |
| Interaction | API5 interactions | 6.81e-04 | 188 | 43 | 4 | int:API5 | |
| Interaction | MIR145 interactions | 6.87e-04 | 81 | 43 | 3 | int:MIR145 | |
| Interaction | SRPK3 interactions | 7.09e-04 | 190 | 43 | 4 | int:SRPK3 | |
| Interaction | MIR10B interactions | 7.13e-04 | 82 | 43 | 3 | int:MIR10B | |
| Interaction | SOX7 interactions | 7.13e-04 | 82 | 43 | 3 | int:SOX7 | |
| Interaction | MIR106A interactions | 7.38e-04 | 83 | 43 | 3 | int:MIR106A | |
| Interaction | MIR7-2 interactions | 7.64e-04 | 84 | 43 | 3 | int:MIR7-2 | |
| Interaction | MIR199A1 interactions | 7.64e-04 | 84 | 43 | 3 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 7.64e-04 | 84 | 43 | 3 | int:MIR200B | |
| Interaction | MIR17 interactions | 7.91e-04 | 85 | 43 | 3 | int:MIR17 | |
| Interaction | MIR18B interactions | 7.91e-04 | 85 | 43 | 3 | int:MIR18B | |
| Interaction | MIR93 interactions | 7.91e-04 | 85 | 43 | 3 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 7.91e-04 | 85 | 43 | 3 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 7.91e-04 | 85 | 43 | 3 | int:MIR16-2 | |
| Interaction | IRF4 interactions | 7.91e-04 | 85 | 43 | 3 | int:IRF4 | |
| Interaction | MIR20B interactions | 8.19e-04 | 86 | 43 | 3 | int:MIR20B | |
| Interaction | TOP3B interactions | 8.57e-04 | 1470 | 43 | 10 | int:TOP3B | |
| Interaction | MIR141 interactions | 8.75e-04 | 88 | 43 | 3 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 8.75e-04 | 88 | 43 | 3 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 9.04e-04 | 89 | 43 | 3 | int:MIR29C | |
| Interaction | MIR221 interactions | 9.34e-04 | 90 | 43 | 3 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 9.34e-04 | 90 | 43 | 3 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 9.64e-04 | 91 | 43 | 3 | int:MIR200C | |
| Interaction | RBM45 interactions | 9.75e-04 | 207 | 43 | 4 | int:RBM45 | |
| Interaction | MIR155 interactions | 9.95e-04 | 92 | 43 | 3 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 9.95e-04 | 92 | 43 | 3 | int:MIR128-1 | |
| Interaction | ACRBP interactions | 1.00e-03 | 22 | 43 | 2 | int:ACRBP | |
| Interaction | CPA5 interactions | 1.00e-03 | 22 | 43 | 2 | int:CPA5 | |
| Interaction | MIR214 interactions | 1.03e-03 | 93 | 43 | 3 | int:MIR214 | |
| Interaction | MIR205 interactions | 1.03e-03 | 93 | 43 | 3 | int:MIR205 | |
| Interaction | MIR19B2 interactions | 1.06e-03 | 94 | 43 | 3 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 1.06e-03 | 94 | 43 | 3 | int:MIRLET7F1 | |
| Interaction | UTY interactions | 1.09e-03 | 23 | 43 | 2 | int:UTY | |
| Interaction | MIRLET7A2 interactions | 1.13e-03 | 96 | 43 | 3 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 1.16e-03 | 97 | 43 | 3 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 1.16e-03 | 97 | 43 | 3 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.16e-03 | 97 | 43 | 3 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 1.16e-03 | 97 | 43 | 3 | int:MIR363 | |
| Interaction | SPIDR interactions | 1.19e-03 | 24 | 43 | 2 | int:SPIDR | |
| Interaction | MIR106B interactions | 1.20e-03 | 98 | 43 | 3 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 1.23e-03 | 99 | 43 | 3 | int:MIR128-2 | |
| Interaction | EIF4E interactions | 1.24e-03 | 221 | 43 | 4 | int:EIF4E | |
| Interaction | RTRAF interactions | 1.26e-03 | 222 | 43 | 4 | int:RTRAF | |
| Interaction | MIR19A interactions | 1.27e-03 | 100 | 43 | 3 | int:MIR19A | |
| Interaction | PIN1 interactions | 1.28e-03 | 383 | 43 | 5 | int:PIN1 | |
| Interaction | RAD21 interactions | 1.30e-03 | 384 | 43 | 5 | int:RAD21 | |
| Interaction | MIRLET7B interactions | 1.30e-03 | 101 | 43 | 3 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 1.30e-03 | 101 | 43 | 3 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 1.30e-03 | 101 | 43 | 3 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 1.34e-03 | 102 | 43 | 3 | int:MIRLET7A3 | |
| Interaction | NFIX interactions | 1.37e-03 | 227 | 43 | 4 | int:NFIX | |
| Interaction | LHX1 interactions | 1.38e-03 | 103 | 43 | 3 | int:LHX1 | |
| Interaction | MIR15B interactions | 1.38e-03 | 103 | 43 | 3 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 1.38e-03 | 103 | 43 | 3 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 1.42e-03 | 104 | 43 | 3 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 1.42e-03 | 104 | 43 | 3 | int:MIR34A | |
| Cytoband | 7q35 | 2.65e-07 | 55 | 45 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 5.55e-07 | 66 | 45 | 4 | chr7q35 | |
| Cytoband | 1p34 | 4.57e-04 | 32 | 45 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 3.02e-03 | 294 | 45 | 3 | chr1p34 | |
| Cytoband | 19q13.33 | 4.90e-03 | 106 | 45 | 2 | 19q13.33 | |
| GeneFamily | CTAGE family | 3.71e-11 | 15 | 32 | 5 | 907 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.64e-03 | 34 | 32 | 2 | 487 | |
| GeneFamily | RNA binding motif containing | 6.22e-03 | 213 | 32 | 3 | 725 | |
| GeneFamily | PHD finger proteins | 1.10e-02 | 90 | 32 | 2 | 88 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.47e-05 | 147 | 45 | 4 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-05 | 166 | 45 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-05 | 166 | 45 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-05 | 166 | 45 | 4 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.42e-05 | 167 | 45 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-05 | 183 | 45 | 4 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-05 | 185 | 45 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 187 | 45 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 187 | 45 | 4 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 187 | 45 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 188 | 45 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 3.85e-05 | 188 | 45 | 4 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 45 | 4 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.18e-05 | 192 | 45 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.35e-05 | 194 | 45 | 4 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | (07)_Ionocytes-(0)_Reference|(07)_Ionocytes / shred by cell type by condition | 4.53e-05 | 196 | 45 | 4 | 4ac33e7d11b8b0fff6ee2e9dacad49c21d63b818 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-05 | 196 | 45 | 4 | 760885dc608c82768fe0decd63ed9fda8315f453 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-05 | 198 | 45 | 4 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-05 | 198 | 45 | 4 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.80e-05 | 199 | 45 | 4 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.80e-05 | 199 | 45 | 4 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 200 | 45 | 4 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 200 | 45 | 4 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 200 | 45 | 4 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 200 | 45 | 4 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 121 | 45 | 3 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.34e-04 | 134 | 45 | 3 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 136 | 45 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 136 | 45 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 137 | 45 | 3 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-04 | 156 | 45 | 3 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | Goblet|World / Class top | 5.31e-04 | 157 | 45 | 3 | b352aa37d662629db6a9c6def9ee6d7c49a9071c | |
| ToppCell | Goblet-gob-1|World / Class top | 5.51e-04 | 159 | 45 | 3 | 62d4ca2b538382419252e306d7a789b64420fb18 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.51e-04 | 159 | 45 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 5.61e-04 | 160 | 45 | 3 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-04 | 160 | 45 | 3 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|(1)_Control_(PBS) / Stress and Cell class | 5.61e-04 | 160 | 45 | 3 | 8450466fc2465c56798df2b520edd23c2c2e941c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-04 | 160 | 45 | 3 | 6005948e400e781cdb876ba350b3ec8991e3945f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-04 | 162 | 45 | 3 | 5428c9fdb816f564395ebb4520448e5f3a42b025 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-04 | 163 | 45 | 3 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.92e-04 | 163 | 45 | 3 | 6c4d4c55fc8a731acca13c1ba7287f238a9d81e0 | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.25e-04 | 166 | 45 | 3 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.58e-04 | 169 | 45 | 3 | 6fe82db874eff0f86e5c0d1cc81322eb9d7874eb | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.58e-04 | 169 | 45 | 3 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 170 | 45 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.69e-04 | 170 | 45 | 3 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 170 | 45 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 170 | 45 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-04 | 172 | 45 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 7.04e-04 | 173 | 45 | 3 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 7.28e-04 | 175 | 45 | 3 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.28e-04 | 175 | 45 | 3 | 36cb3c8116bd467ee5da0630d8b3d3e4afcc2ded | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 7.40e-04 | 176 | 45 | 3 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.40e-04 | 176 | 45 | 3 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-04 | 177 | 45 | 3 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.52e-04 | 177 | 45 | 3 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-04 | 177 | 45 | 3 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-04 | 177 | 45 | 3 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 178 | 45 | 3 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 178 | 45 | 3 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.77e-04 | 179 | 45 | 3 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-04 | 180 | 45 | 3 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 180 | 45 | 3 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 180 | 45 | 3 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 064057ab36c6d92c36572b73142b42d201709d7b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 8.15e-04 | 182 | 45 | 3 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.15e-04 | 182 | 45 | 3 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.15e-04 | 182 | 45 | 3 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 8.15e-04 | 182 | 45 | 3 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 8.28e-04 | 183 | 45 | 3 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 8.28e-04 | 183 | 45 | 3 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.28e-04 | 183 | 45 | 3 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 8.28e-04 | 183 | 45 | 3 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.28e-04 | 183 | 45 | 3 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.28e-04 | 183 | 45 | 3 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-04 | 184 | 45 | 3 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-04 | 184 | 45 | 3 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 184 | 45 | 3 | 69348c9237e44f7752ac01f60e733ad41580fdb8 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 184 | 45 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.55e-04 | 185 | 45 | 3 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.55e-04 | 185 | 45 | 3 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | 62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-04 | 186 | 45 | 3 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.79e-06 | 2 | 40 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 1.79e-05 | 5 | 40 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Motor Skills Disorders | 4.99e-05 | 8 | 40 | 2 | C0026613 | |
| Disease | Developmental Coordination Disorder | 4.99e-05 | 8 | 40 | 2 | C0011757 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 1.86e-04 | 15 | 40 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 6.16e-04 | 27 | 40 | 2 | C0036920 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.90e-04 | 139 | 40 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 1.24e-03 | 156 | 40 | 3 | DOID:10283 (is_marker_for) | |
| Disease | stromal cell-derived factor 1 alpha measurement | 1.56e-03 | 43 | 40 | 2 | EFO_0008293 | |
| Disease | Anxiety Disorders | 1.64e-03 | 44 | 40 | 2 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 1.64e-03 | 44 | 40 | 2 | C1279420 | |
| Disease | Anxiety States, Neurotic | 1.64e-03 | 44 | 40 | 2 | C0376280 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.71e-03 | 45 | 40 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | pulse pressure measurement | 2.43e-03 | 1392 | 40 | 7 | EFO_0005763 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.73e-03 | 57 | 40 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 2.73e-03 | 57 | 40 | 2 | EFO_0000768 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRRMGLYPGLEGFRP | 136 | Q9NXW9 | |
| RSMLRGGPLPGPYRL | 76 | P07451 | |
| YGSLSRGLGMRPPRA | 201 | O00192 | |
| PGTMFGASRGYFPPR | 726 | Q8IX94 | |
| PGTMFGASRGYFPPR | 726 | Q86UF2 | |
| PGTMFGASRGYFPPR | 726 | P0CG41 | |
| PGTMFGASRGYFPPR | 726 | A4FU28 | |
| PGTMFGASRGYFPPR | 726 | A4D2H0 | |
| PRPMLRFYLIGGGIP | 871 | Q8IWK6 | |
| RRPGYMRSSTGPGIG | 41 | Q9NRI5 | |
| GGFPRYRPPQGMRYS | 1191 | Q9BXF3 | |
| RGPGGDPPYKIRYMG | 976 | Q9HC84 | |
| RRRPPKGMYLSPEGL | 256 | Q8IZ40 | |
| MYKDPRTGGSGPARP | 486 | Q5U651 | |
| MFPPGTRGRARGLPY | 191 | Q96DH6 | |
| SPLPPMGTRRAYLGV | 466 | Q9Y573 | |
| GGFLYFARRPPGRPG | 216 | Q9NRN5 | |
| MAYRVLGRAGPPQPR | 1 | Q9Y278 | |
| PGDRRTGPPMGSRFR | 171 | Q15056 | |
| KPYRPGIGGFMVRQR | 1276 | Q8NEZ4 | |
| APIPMGGRAYPKRSA | 1146 | Q9Y3R5 | |
| LVRGPRPQGMRSPYR | 6 | A0A087WWA1 | |
| RPQGMRSPYRRPGMG | 11 | A0A087WWA1 | |
| PLGLYARMRRLPGPE | 26 | Q330K2 | |
| ARLALRGPPGPMGYT | 481 | P13942 | |
| RFPPARPGSLGVMEY | 141 | Q96CB9 | |
| MVRPRRAPYRSGAGG | 1 | Q86YD1 | |
| KPGMRRRIIGYGLPF | 286 | Q9UDY4 | |
| ERPRPGGRYRPGYGT | 191 | P28300 | |
| PPRDYPGAMAGRFGS | 3126 | Q9NYQ7 | |
| GSTRYGDGPRPPKMA | 1151 | Q08211 | |
| GVPYPPFMPRRLTGR | 356 | Q9H0F5 | |
| FMSPRYAGGPRPPIR | 151 | Q9BWW4 | |
| QTGPPPSYRPGLRMF | 751 | Q14934 | |
| PSYRPGLRMFPETRG | 756 | Q14934 | |
| PGRGGRPMPPSRRDY | 266 | P61978 | |
| PGFPARPGRGRPYMA | 31 | Q9UQ90 | |
| RPGRGRPYMASRPPG | 36 | Q9UQ90 | |
| RGPRPNPAIMRGRYG | 1921 | Q99466 | |
| MYVPARSGRGRKGPL | 1096 | Q9Y566 | |
| GAGFFIRRRMYPPPL | 76 | Q96AW1 | |
| NMYRGYRPRFRRGPP | 236 | P67809 | |
| GRGGGPSPRYRLEPM | 81 | Q9P227 | |
| MLAGPGGYPPRRDDR | 911 | Q9H0D6 | |
| AGMGSYVPPRRLAVP | 106 | O00488 | |
| SMGLPRFYPAGRARG | 36 | Q14966 | |
| PYRPGIGGFMVRQRK | 1691 | O14686 | |
| KGRIRRGNYPGPSSP | 2281 | B2RTY4 |